See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
No Insider Transactions found for NovaBridge Biosciences
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Sep 18, 2026 Dennis Phillip Andrew |
Dennis Phillip Andrew
CMO
|
Sell |
8,209 | $0.71 | 8,209 $0.71 $5,828 |
Sep 09, 2026 Cao Sean Wuxiong |
Cao Sean Wuxiong
|
Sell |
107,978 | $0.74 | 107,978 $0.74 $79,904 |
Aug 31, 2026 Xu Cong Claire |
Xu Cong Claire
EVP, Clinical Development
|
Sell |
3,282 | $0.79 | 3,282 $0.79 $2,593 |
Jul 06, 2026 Xu Cong Claire |
Xu Cong Claire
|
Sell |
4,485 | $0.89 | 4,485 $0.89 $3,992 |
Jun 18, 2026 Dennis Phillip Andrew |
Dennis Phillip Andrew
CMO
|
Sell |
8,494 | $0.66 | 8,494 $0.66 $5,606 |
Jun 01, 2026 Xu Cong Claire |
Xu Cong Claire
SVP, Clinical Development
|
Sell |
3,494 | $3.94 | 3,494 $3.94 $13,766 |
May 14, 2026 Cao Sean Wuxiong |
Cao Sean Wuxiong
See Remarks
|
Sell |
21,399 | $1.99 | 21,399 $1.99 $42,584 |
Apr 24, 2026 Hagler Mark Arnold |
Hagler Mark Arnold
See Remarks
|
Buy |
230,000 | $2.51 | 230,000 $2.51 $577,300 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
No Historical Insider Transactions found for NovaBridge Biosciences
TOP
